A. Thavamani

Most-cited papers

1. Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity

   A. Chougule, K. Prabhash, V. Noronha, A. Joshi +7 more

   2013PLoS ONE121 citations Open access

   Semantic Scholar

   Save

2. EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted Therapy

   V. Noronha, K. Prabhash, A. Thavamani, A. Chougule +7 more

   2013PLoS ONE79 citations Open access

   Semantic Scholar

   Save

3. PARP-inhibition reprograms macrophages toward an anti-tumor phenotype

   Lin Wang, Dan Wang, Olmo Sonzogni, S. Ke +18 more

   2022Cell Reports44 citations Open access

   Semantic Scholar

   Save

4. Dysregulated serum response factor triggers formation of hepatocellular carcinoma

   Stefan Ohrnberger, A. Thavamani, A. Braeuning, D. Lipka +12 more

   2015Hepatology38 citations Open access

   Semantic Scholar

   Save

5. The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma

   Constanze Hermanns, V. Hampl, K. Holzer, Achim Aigner +13 more

   2017Oncogene36 citations Open access

   Semantic Scholar

   Save

6. Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment

   Ivana Winkler, C. Bitter, Sebastian Winkler, D. Weichenhan +8 more

   2019Proceedings of the National Academy of Sciences of the United States of America25 citations Open access

   Semantic Scholar

   Save

7. Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

   A. Choughule, Rk Sharma, Vaishakhi Trivedi, A. Thavamani +11 more

   2014British Journal of Cancer13 citations Open access

   Semantic Scholar

   Save

8. Serum Response Factor (SRF) Drives the Transcriptional Upregulation of the MDM4 Oncogene in HCC

   R. Pellegrino, A. Thavamani, D. Calvisi, J. Budczies +7 more

   2021Cancers9 citations Open access

   Semantic Scholar

   Save

9. Vps4A-mediated tumor suppression upon exosome modulation?

   Ivana Akrap, A. Thavamani, A. Nordheim

   2016Annals of Translational Medicine5 citations Open access

   Semantic Scholar

   Save

10. Reciprocal inhibition of PIN1 and APC/CCDH1 controls timely G1/S transition and creates therapeutic vulnerability

    S. Ke, Fabin Dang, Lin Wang, Jia-Yun Chen +20 more

    2023Research Square2 citations Open access

    Semantic Scholar

    Save

11. The interaction of Serum Response Factor (SRF) and ETS domain transcription factors regulate the transcription of the MDM 4 oncogene in HCC

    R. Pellegrino, A. Thavamani, D. Calvisi, A. Neumann +5 more

    2019Zeitschrift für Gastroenterologie - German Journal of Gastroenterology1 citations

    Semantic Scholar

    Save

12. 513 Adverse association between gastrointestinal disorders and anxiety/depression among people with cystic fibrosis

    S. Sankararaman, T. Sferra, A. Thavamani

    2025Journal of Cystic Fibrosis0 citations

    Semantic Scholar

    Save

13. Integrated multi-omic analysis of HCC formation in the SRF-VP16 iHep mouse model

    A. Thavamani

    20160 citations

    Semantic Scholar

    Save

14. Serum Reponse Factor (SRF) is a transcriptional activator of Mouse Double Minute 4 (MDM4) in hepatocellular carcinoma

    R. Pellegrino, A. Thavamani, R. Geffers, P. Schirmacher +2 more

    20150 citations

    Semantic Scholar

    Save

15. The Serum Reponse Factor (SRF) is involved in the transcriptional upregulation of the functional p53 inhibitor MDM 4 in hepatocellular carcinoma

    R. Pellegrino, A. Thavamani, R. Geffers, P. Schirmacher +2 more

    20140 citations

    Semantic Scholar

    Save